Marthe Verhaert (@martheverhaert) 's Twitter Profile
Marthe Verhaert

@martheverhaert

MD | PhD candidate in immunotoxicity | BITOX board member

ID: 82409090

calendar_today14-10-2009 17:20:43

27 Tweet

49 Followers

75 Following

Belgian ImmunoToxicity board (@bitoxbsmo) 's Twitter Profile Photo

📌 Launching in June: the #HCC podcast expert series 🎙 Using #podcasts to keep physicians informed on the newest insights in HCC treatment, with #ICI as new kids on the block 🏥 ⏩ A great initiative to improve information dissemination and thus #safety of treatment!

UZ Brussel (@uzbrussel) 's Twitter Profile Photo

Nog meer onderzoeksnieuws! Sandrine Aspeslagh en collega's zullen een plant-gebaseerd dieet implementeren bij onco-patiënten die immuuntherapie krijgen om te evalueren of de toxiciteit zo kan worden gereduceerd #FORX

Laura Vater, MD, MPH (@doclauravater) 's Twitter Profile Photo

New data: Long hours (≥60 per week) & extended shifts (≥24 hours) pose a danger to patient safety & to residents. The combination has a synergistic effect, amplifying medical errors, car crashes, and needle sticks. It’s time to rethink the way we’ve always done things.

New data: Long hours (≥60 per week) & extended shifts (≥24 hours) pose a danger to patient safety & to residents. 

The combination has a synergistic effect, amplifying medical errors, car crashes, and needle sticks.

It’s time to rethink the way we’ve always done things.
Sacha Goovaerts (@sachagoovaerts) 's Twitter Profile Photo

A new week, a fresh podcast on #livercancer( HCC ) Marthe Verhaert and Pieter-Jan Cuyle discuss the safety profile of new combinations and immunotherapy more generally. What should you pay attention to as a physician when initiating a new therapy? Listen now rochepro.be/nl/wetenschapp…

A new week, a fresh podcast on #livercancer( HCC )  <a href="/martheverhaert/">Marthe Verhaert</a> and <a href="/PJCuyle/">Pieter-Jan Cuyle</a>  discuss the safety profile of new combinations and immunotherapy more generally. What should you pay attention to as a physician when initiating a new therapy? Listen now rochepro.be/nl/wetenschapp…
Marthe Verhaert (@martheverhaert) 's Twitter Profile Photo

One of the motivations we developed the #FORX trial to investigate how 🥦🍐🍏🍒🥕 can improve #immunotherapy outcome. All support 🪙 is welcome to start our study asap act.uzbrusselfoundation.be/nl-NL/project/…

Belgian ImmunoToxicity board (@bitoxbsmo) 's Twitter Profile Photo

Marthe Verhaert presenting our 2y experience of the #multidisciplinary #bitox meetings at #sitc2023 💪🏻 📈 a steady rise in cases show the accessibility and popularity 🫵 we keep looking for motivated #oncologists and #organ specialists to join 💌 us at [email protected] for more ℹ️

<a href="/martheverhaert/">Marthe Verhaert</a> presenting our 2y experience of the #multidisciplinary #bitox meetings at #sitc2023 💪🏻

📈 a steady rise in cases show the accessibility and popularity
🫵 we keep looking for motivated #oncologists and #organ specialists to join
💌 us at bitox@bsmo.be for more ℹ️
Marthe Verhaert (@martheverhaert) 's Twitter Profile Photo

Proud to be alongside my #colleague Manon Vounckx showing safety and feasibility of #SBRT in combination with systemic +/- local #checkpointinhibition at #sitc2023 👏🏻

Proud to be alongside my #colleague Manon Vounckx showing safety and feasibility of #SBRT in combination with systemic +/- local #checkpointinhibition at #sitc2023 👏🏻
Nature Rev Immunol (@natrevimmunol) 's Twitter Profile Photo

NEW Review: Role of the microbiota in response to and recovery from cancer therapy bit.ly/3sqTZDN by Stephen Blake Yochai Wolf, Ben Boursi & David Lynn discusses mechanisms by which the microbiota alters the efficacy and immunotoxicity of cancer treatment

NEW Review: Role of the microbiota in response to and recovery from cancer therapy
bit.ly/3sqTZDN
by <a href="/StephenBlakeAU/">Stephen Blake</a> Yochai Wolf, Ben Boursi &amp; <a href="/davidjohnlynn/">David Lynn</a> 
discusses mechanisms by which the microbiota alters the efficacy and immunotoxicity of cancer treatment
Belgian Society of Medical Oncology (@mybsmo) 's Twitter Profile Photo

This March, our Belgian Society of Medical Oncology Belgian ImmunoToxicity board 🇧🇪 ImmunoToxicity board exists 3 years and has discussed over 260 #irAE or #dysimmunity cases!🥳 Want to #join or share #feedback? Head to 🌐 bsmo.be/bitox or 📩 [email protected]!

Marthe Verhaert (@martheverhaert) 's Twitter Profile Photo

📰 European Journal of Cancer just #published my #review on what patients can influence themselves when starting #immunotherapy. I summarize the evidence behind 🍽 , 💊 and 👟, highlighting patient #empowerment. ➡️doi.org/10.1016/j.ejca…

Anouk Goudsmit (@anoukgoudsmit) 's Twitter Profile Photo

A superb poster by Marthe Verhaert at #ESMO24 to present the results of the amazing work they are doing with the BITOX, the Belgian ImmunoTOXicity board of Belgian Society of Medical Oncology, thanks for being there to guide us in the treatment of rare and tricky toxicities 🤔🤓

A superb poster by <a href="/martheverhaert/">Marthe Verhaert</a> at #ESMO24 to present the results of the amazing work they are doing with the BITOX, the Belgian ImmunoTOXicity board of <a href="/mybsmo/">Belgian Society of Medical Oncology</a>, thanks for being there to guide us in the treatment of rare and tricky toxicities 🤔🤓
Kennismakers Magazine (@fwokennismakers) 's Twitter Profile Photo

Een kankerdiagnose kan je overweldigen, maar wat als je de behandeling zelf een duwtje in de rug kunt geven met aanpassingen in je voeding? Marthe Verhaert (VUB) onderzoekt het met steun van het FWO én Delhaize! Lees het interview op kennismakers.be/op-speeddate-m… #kennismakers

Een kankerdiagnose kan je overweldigen, maar wat als je de behandeling zelf een duwtje in de rug kunt geven met aanpassingen in je voeding?
Marthe Verhaert (VUB) onderzoekt het met steun van het FWO én Delhaize!
Lees het interview op kennismakers.be/op-speeddate-m…
#kennismakers
Anouk Goudsmit (@anoukgoudsmit) 's Twitter Profile Photo

I'm really proud to be part of this dynamic and motivated team, the Young Oncologists Committee of the Belgian Society of Medical Oncology 💥 Keep posted for new scientific and networking projects for Belgian YO 🦀

I'm really proud to be part of this dynamic and motivated team, the Young Oncologists Committee of the <a href="/mybsmo/">Belgian Society of Medical Oncology</a> 💥 Keep posted for new scientific and networking projects for Belgian YO 🦀
Marthe Verhaert (@martheverhaert) 's Twitter Profile Photo

Great memories from the Belgian Society of Medical Oncology meeting in #Bruges! Sandrine Aspeslagh presented our #FORX 🥕 trial, and I had the chance to highlight the 3-year anniversary of Belgian ImmunoToxicity board and moderate the second #YOC session. Our national #network earned the best oral presentation award 👑!

Great memories from the <a href="/mybsmo/">Belgian Society of Medical Oncology</a> meeting in #Bruges! <a href="/sandrineaspesla/">Sandrine Aspeslagh</a> presented our #FORX 🥕 trial, and I had the chance to highlight the 3-year anniversary of <a href="/BITOXbsmo/">Belgian ImmunoToxicity board</a> and moderate the second #YOC session. Our national #network earned the best oral presentation award 👑!
Belgian ImmunoToxicity board (@bitoxbsmo) 's Twitter Profile Photo

We exist 4 years! 🎉 How can we #improve? 📬 Let's hear your #feedback via this quick survey: vub.fra1.qualtrics.com/jfe/form/SV_0I…

We exist 4 years! 🎉
How can we #improve?
📬 Let's hear your #feedback via this quick survey: vub.fra1.qualtrics.com/jfe/form/SV_0I…
MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

A high fiber dietary intervention significantly improved response to immunotherapy in patients with melanoma receiving immune checkpoint blockade therapy. Our postdoctoral fellow Dr. Yufan Simon Qiu shared results at #ASCO25. Learn more: bit.ly/4mGk4pO Nazli Dizman

A high fiber dietary intervention significantly improved response to immunotherapy in patients with melanoma receiving immune checkpoint blockade therapy. Our postdoctoral fellow Dr. Yufan Simon Qiu shared results at #ASCO25. Learn more: bit.ly/4mGk4pO <a href="/NazliDizman/">Nazli Dizman</a>